Early-onset VAP | Late-onset VAP |
---|---|
Second or third generation cephalosporin: e. g., ceftriaxone: 2 g daily; | Cephalosporin |
cefuroxime: 1.5 g every 8 hours; | e. g., cefepime: 1-2 g every 8 hours; |
cefotaxime: 2 g every 8 hours | ceftazidime 2 g every 8 hours |
OR | OR |
Fluoroquinolones | Carbepenem |
e. g., levofloxacin: 750 mg daily; | e. g., imipenem + cilastin: 500 mg every 6 hours or 1 g every 8 hours; |
moxifloxacin: 400 mg daily | meropenem: 1 g every 8 hours |
OR | OR |
Aminopenicillin + beta-lactamase inhibitor e. g., ampicillin + sulbactam: 3 g | Beta-lactam/beta-lactamase inhibitor |
every 8 hours | e. g., piperacillin + tazobactam: 4.5 g every 6 hours |
OR | PLUS |
Ertapenem | Aminoglycoside |
1 g daily | e. g., amikacin: 20 mg/kg/day; |
 | gentamicin: 7 mg/kg/day; |
 | tobramycin: 7 mg/kg/day |
 | OR |
 | Antipseudomonal fluoroquinolone |
 | e. g., ciprofloxacin 400 mg every 8 hours; |
 | levofloxacin 750 mg daily |
 | PLUS |
 | Coverage for MRSA |
 | e. g., vancomycin: 15 mg/kg every 12 hours |
 | OR |
 | linezolid: 600 mg every 12 hours |